DJIA 17,778.15 421.28 2.43%
NASDAQ 4,748.40 104.08 2.24%
S&P 500 2,061.23 48.34 2.40%
market minute promo

ACTAVIS (NYSE: ACT)

263.75 2.85 (1.09%)

REAL-TIME: Last trade at

Extended Hours: $263.75 $0.00 (0.00%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

ACT $263.75 1.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $264.70
Previous Close $260.90
Daily Range $262.19 - $268.37
52-Week Range $158.57 - $272.75
Market Cap $69.9B
P/E Ratio -51.26
Dividend (Yield) $0.00 (0.0%)
Volume 3,313,878
Average Daily Volume 3,722,856
Current FY EPS $13.57

Sector

Healthcare

Industry

Drugs

ACTAVIS (ACT) Description

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products. Website: http://www.actavis.com/

News & Commentary

Billionaires Are Loading Up On These 3 Stocks

The 10 largest hedge funds bought nearly $16 billion worth of stocks in the third quarter, and three of them were their favorites.

Emergent BioSolutions Buys EV-035 Series from Evolva - Analyst Blog

Ackman: Allergan Is A Good Merger Arbitrage Play, Potential 28% Upside

9 Big Stocks That Doubled in 2014

Cyclacel Falls on Poor Acute Myeloid Leukemia Drug Data - Analyst Blog

Alexion Announces New Share Repurchase Program of $500M - Analyst Blog

Actavis to Appeal Ruling Regarding Namenda IR Sales - Analyst Blog

Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisi

Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition

ChemoCentryx Up on Positive Diabetic Nephropathy Data - Analyst Blog

Buffett and Billionaire Investors Look to Oil, Health Care and Spinoffs in 2015

See More ACT News...

ACT's Top Competitors

ACT $263.75 (1.09%)
Current stock: ACT
JNJ $106.81 (2.63%)
Current stock: JNJ
NVS $94.57 (2.47%)
Current stock: NVS
RHHBY $36.90 (2.39%)
Current stock: RHHBY